AgomAb Therapeutics
Updated: July 26, 2026
CEO Tim Knotnerus
Country: Belgium | Funding: $325.6M (+)
Founded: 2017
Website: https://agomab.com/
AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.
Founded: 2017
Website: https://agomab.com/
AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.
